Pharma Journalist - Page 824 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

First Patient Enrolled in Phase 3 Trial for ATIR101 in Adult Patients with Blood Cancer

Mylan and Aspen announce Launch of Generic Busulfex Injection

Sunovion receives FDA approval for Lonhala Magnair Inhalation Solution to Treat COPD

New Confirmed Delegates & Speakers for RNA Therapeutics

Lilly initiates clinical trial to evaluate the functionality and safety of its AID System

EMA accepts marketing application for Trastuzumab and Pegfilgrastim

Andrew Hopkins, Chief Executive at Exscientia to discuss the role of Artificial Intelligence in small molecule drug discovery

GSK submits US regulatory application for single-dose tafenoquine for P. vivax malaria

Titan Pharmaceuticals Partners with Molteni to Market Probuphine in Europe

BIOCAD Launches the New Manufacturing Site in North Africa